Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NALOXONE vs NAPROXEN\SUMATRIPTAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NALOXONE vs NAPROXEN\SUMATRIPTAN: Safety Overview

Metric NALOXONE NAPROXEN\SUMATRIPTAN
Total FAERS Reports 2,859 233
Deaths Reported 779 15
Death Rate 27.2% 6.4%
Hospitalizations 1,033 14
Average Patient Age 43.8 yrs 47.8 yrs
% Female Patients 44.6% 84.5%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Meitheal Pharmaceuticals Inc. N/A
Route INTRAMUSCULAR N/A
Marketing Status Discontinued N/A